Ankylosing spondylitis Trials in Toruń, Poland
Conditions / Ankylosing spondylitis / Toruń, Poland
Ankylosing spondylitis has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03355573 | A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis | COMPLETED | PHASE2 |
| NCT03117270 | A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis | COMPLETED | PHASE2 |
| NCT01786668 | Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis | COMPLETED | PHASE2 |
| NCT02505542 | Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo | COMPLETED | PHASE3 |
| NCT04156620 | Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA | COMPLETED | PHASE3 |
| NCT01061723 | Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis | COMPLETED | PHASE2 |
| NCT03215277 | A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis | COMPLETED | PHASE2 |
| NCT02963506 | A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis | COMPLETED | PHASE2 |
| NCT04436640 | A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis | ACTIVE_NOT_RECRUITING | — |
| NCT03928743 | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis | COMPLETED | PHASE3 |